{"organizations": [], "uuid": "d5cd98b55e2510efcf8d256766c32f992231b566", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-array-biopharma-reports-q3-loss-pe/brief-array-biopharma-reports-q3-loss-per-share-0-11-idUSASC0A0YX", "country": "US", "domain_rank": 408, "title": "BRIEF-Array Biopharma Reports Q3 Loss Per Share $0.11", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T15:03:00.000+03:00", "replies_count": 0, "uuid": "d5cd98b55e2510efcf8d256766c32f992231b566"}, "author": "", "url": "https://www.reuters.com/article/brief-array-biopharma-reports-q3-loss-pe/brief-array-biopharma-reports-q3-loss-per-share-0-11-idUSASC0A0YX", "ord_in_thread": 0, "title": "BRIEF-Array Biopharma Reports Q3 Loss Per Share $0.11", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-array biopharma reports", "sentiment": "negative"}, {"name": "biopharma inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 9, 2018 / 12:07 PM / Updated 10 minutes ago BRIEF-Array Biopharma Reports Q3 Loss Per Share $0.11 Reuters Staff\nMay 9 (Reuters) - Array Biopharma Inc:\n* ARRAY BIOPHARMA REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER OF FISCAL 2018 * Q3 REVENUE VIEW $31.7 MILLION — THOMSON REUTERS I/B/E/S\n* Q3 EARNINGS PER SHARE VIEW $-0.22 — THOMSON REUTERS I/B/E/S\n* CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF MARCH 31, 2018 WERE $440 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-05-09T15:03:00.000+03:00", "crawled": "2018-05-09T15:21:48.012+03:00", "highlightTitle": ""}